methyl (2S)-3-(4-amino-3-bromophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate | 850317-58-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl (2S)-3-(4-amino-3-bromophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate
• 英文别名: Methyl (2S)-3-(4-amino-3-bromophenyl)-2-[(tert-butoxycarbonyl)amino]-propanoate；methyl (2S)-3-(4-amino-3-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
• CAS: 850317-58-7
• 化学式: C₁₅H₂₁BrN₂O₄
• 分子量: 373.247
• InChiKey: WPNASYLGZKANMQ-LBPRGKRZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  22
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  90.6
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl (2S)-3-(4-amino-3-bromophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate 在 吡啶 lithium hydroxide 、 copper(l) iodide 、 N-羟基-7-氮杂苯并三氮唑 、 N,N-二甲基甘氨酸盐酸盐 、 caesium carbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 38.58h， 生成 (9S,12S)-9-[(tert-butoxycarbonyl)amino]-10-oxo-4-[(2,2,2-trifluoroacetyl)amino]-2-oxa-11-azatricyclo[12.2.2.1^3,7]nonadeca-1(17),3(19),4,6,14(18),15-hexaene-12-carboxylic acid methyl ester
  参考文献：
  名称：

  轻度的Ullmann型联芳醚通过邻位取代基和配体作用的结合而形成反应。

  摘要：

  DOI：

  10.1002/anie.200503538
• 作为产物：
  描述：

  甲基N-{[(2-甲基-2-丙基)氧基]羰基}-4-硝基苯丙氨酸酯 在 N-溴代丁二酰亚胺(NBS) 、 ammonium chloride 、 锌 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 methyl (2S)-3-(4-amino-3-bromophenyl)-2-[(tert-butoxycarbonyl)amino]propanoate
  参考文献：
  名称：

  Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (S)-Isothiazolidinone Phosphotyrosine Mimetic

  摘要：

  Potent nonpeptidic benzimidazole sulfonamide inhibitors of protein tyrosine phosphatase 1B (PTP1B) were derived from the optimization of a tripeptide containing the novel (S)-isothiazolidinone ((S)-IZD) phosphotyrosine ( pTyr) mimetic. An X-ray cocrystal structure of inhibitor 46/PTP1B at 1.8 angstrom resolution demonstrated that the benzimidazole sulfonamides form a bidentate H bond to Asp48 as designed, although the aryl group of the sulfonamide unexpectedly interacts intramolecularly in a pi-stacking manner with the benzimidazole. The ortho substitution to the (S)-IZD on the aryl ring afforded low nanomolar enzyme inhibitors of PTP1B that also displayed low caco-2 permeability and cellular activity in an insulin receptor (IR) phosphorylation assay and an Akt phosphorylation assay. The design, synthesis, and SAR of this novel series of benzimidazole sulfonamide containing (S)-IZD inhibitors of PTP1B are presented herein.

  DOI：

  10.1021/jm0600904

文献信息

• Inhibitors of proteins that bind phosphorylated molecules
  申请人：Combs P. Andrew

  公开号：US20050272778A1

  公开（公告）日：2005-12-08

  The present invention provides compounds that can modulate the activity of a target protein, such as a phosphatase, that selectively binds phosphorylated peptides or proteins. The present compounds can be useful in treating diseases or disorders, including, for example, diabetes and obesity, that are connected directly or indirectly to the activity of the target protein.

  本发明提供了可以调节目标蛋白活性的化合物，例如选择性结合磷酸化肽或蛋白质的磷酸酶。这些化合物可以用于治疗与目标蛋白活性直接或间接相关的疾病或障碍，例如糖尿病和肥胖症。
• Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic (<i>S</i>)-Isothiazolidinone Phosphotyrosine Mimetic
  作者：Andrew P. Combs、Wenyu Zhu、Matthew L. Crawley、Brian Glass、Padmaja Polam、Richard B. Sparks、Dilip Modi、Amy Takvorian、Erin McLaughlin、Eddy W. Yue、Zelda Wasserman、Michael Bower、Min Wei、Mark Rupar、Paul J. Ala、Brian M. Reid、Dawn Ellis、Lucie Gonneville、Thomas Emm、Nancy Taylor、Swamy Yeleswaram、Yanlong Li、Richard Wynn、Timothy C. Burn、Gregory Hollis、Phillip C. C. Liu、Brian Metcalf

  DOI：10.1021/jm0600904

  日期：2006.6.1

  Potent nonpeptidic benzimidazole sulfonamide inhibitors of protein tyrosine phosphatase 1B (PTP1B) were derived from the optimization of a tripeptide containing the novel (S)-isothiazolidinone ((S)-IZD) phosphotyrosine ( pTyr) mimetic. An X-ray cocrystal structure of inhibitor 46/PTP1B at 1.8 angstrom resolution demonstrated that the benzimidazole sulfonamides form a bidentate H bond to Asp48 as designed, although the aryl group of the sulfonamide unexpectedly interacts intramolecularly in a pi-stacking manner with the benzimidazole. The ortho substitution to the (S)-IZD on the aryl ring afforded low nanomolar enzyme inhibitors of PTP1B that also displayed low caco-2 permeability and cellular activity in an insulin receptor (IR) phosphorylation assay and an Akt phosphorylation assay. The design, synthesis, and SAR of this novel series of benzimidazole sulfonamide containing (S)-IZD inhibitors of PTP1B are presented herein.
• Mild Ullmann-Type Biaryl Ether Formation Reaction by Combination ofortho-Substituent and Ligand Effects
  作者：Qian Cai、Benli Zou、Dawei Ma

  DOI：10.1002/anie.200503538

  日期：2006.2.13